Civic AI
Procurement intelligence
Federal contract award
TO DEVELOP AN ORALLY AVAILABLE SMALL MOLECULE ANTIVIRAL DRUG, WITH TREATMENT OF YELLOW FEVER VIRUS INFECTION AS THE PRIMARY INDICATION.
BARUCH S. BLUMBERG INSTITUTE · Department of Health and Human Services
- Value
- $16,240,850
- Start
- Nov 15, 2022
- End
- Nov 30, 2027
- Action date
- May 14, 2026
- PIID
- 75N93023C00003
- Status
- active
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- DOYLESTOWN, PA
- Award type
- DEFINITIVE CONTRACT
Description
TO DEVELOP AN ORALLY AVAILABLE SMALL MOLECULE ANTIVIRAL DRUG, WITH TREATMENT OF YELLOW FEVER VIRUS INFECTION AS THE PRIMARY INDICATION.
Need modifications, related awards, and vendor peers? Open the full award workspace.